Abstract

Background: Endodontic diagnosis usually assumes that pain, tenderness, swelling, sensibility test responses, and radiographic change reflect the interaction between microbial irritation and host response. Under altered host immunity, this relationship becomes less predictable because disease activity and disease expression may no longer progress in parallel. Biologically important pulpal or periapical disease may therefore appear deceptively mild, whereas competing oral or systemic conditions may complicate localization and interpretation. 

Objectives: To examine how altered host immunity changes the diagnostic expression of pulpal and periapical disease, distinguish immune suppression from immune dysregulation as biologically distinct states, and propose a practical clinical approach to diagnostic uncertainty in these patients. 

Results: Altered host immunity changed the diagnostic meaning of conventional endodontic findings in two broad directions. Immune suppression tended to attenuate inflammatory expression, with reduced pain, swelling, and delayed radiographic change, thereby increasing the risk of under-recognition. Immune dysregulation tended to reduce interpretive clarity through chronic inflammatory activity, mucosal disease, xerostomia, neuropathic overlap, and treatment-related oral change, thereby increasing the risk of misdirection or misdiagnosis. Conventional tests retained clinical value, but isolated interpretation became less secure. A practical five-step response was therefore proposed: define the immune context, classify the presentation pattern, interpret findings together, escalate imaging when needed, and recognize red flags early. 

Conclusion: Altered host immunity does not invalidate conventional endodontic diagnosis. However, it requires more cautious and context-sensitive interpretation. Safer diagnosis depends on integration of medical history, tooth-specific examination, imaging, and reassessment over time, together with patience and empathy when uncertainty persists. 

Al-Hamadani, M., Darweesh, M., Mohammadi, S., & Al-Harrasi, A. (2025). Chloroquine and hydroxychloroquine: Immunomodulatory effects in autoimmune diseases. World Journal of Biological Chemistry, 16(2), 107042. https://doi.org/10.4331/wjbc.v16.i2.107042

al-Hashimi I. (2001). The management of Sjögren's syndrome in dental practice. Journal of the American Dental Association, 132(10), 1409–1461. https://doi.org/10.14219/jada.archive.2001.0056

Al Johani, K., Fudah, M., Al-Zahrani, M., Abed, H., Srivastava, K. C., Shrivastava, D., Cicciù, M., & Minervini, G. (2023). Multiple Sclerosis-A Demyelinating Disorder and Its Dental Considerations-A Literature Review with Own Case Report. Brain Sciences, 13(7), 1009. https://doi.org/10.3390/brainsci13071009

Alexander, M., Cho, E., Gliozheni, E., Salem, Y., Cheung, J., & Ichii, H. (2024). Pathology of Diabetes-Induced Immune Dysfunction. International Journal of Molecular Sciences, 25(13), 7105. https://doi.org/10.3390/ijms25137105

Allihaibi, M., Niazi, S. A., Farzadi, S., Austin, R., Ideo, F., Cotti, E., & Mannocci, F. (2023). Prevalence of apical periodontitis in patients with autoimmune diseases: A case-control study. International Endodontic Journal, 56(5), 573–583. https://doi.org/10.1111/iej.13902

Andrada, A. C., Azuma, M. M., Furusho, H., Hirai, K., Xu, S., White, R. R., & Sasaki, H. (2020). Immunomodulation Mediated by Azithromycin in Experimental Periapical Inflammation. Journal of Endodontics, 46(11), 1648–1654. https://doi.org/10.1016/j.joen.2020.07.028

Baldini, C., Fulvio, G., La Rocca, G., & Ferro, F. (2024). Update on the pathophysiology and treatment of primary Sjögren syndrome. Nature Reviews. Rheumatology, 20(8), 473–491. https://doi.org/10.1038/s41584-024-01135-3

Ballow, M., Sánchez-Ramón, S., & Walter, J. E. (2022). Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases. Frontiers in Immunology, 13, 928062. https://doi.org/10.3389/fimmu.2022.928062

Berbudi, A., Rahmadika, N., Tjahjadi, A. I., & Ruslami, R. (2020). Type 2 Diabetes and its Impact on the Immune System. Current Diabetes Reviews, 16(5), 442–449.  https://doi.org/10.2174/1573399815666191024085838

Cain, D. W., & Cidlowski, J. A. (2017). Immune regulation by glucocorticoids. Nature Reviews. Immunology, 17(4), 233–247. https://doi.org/10.1038/nri.2017.1

Callegari, I., Derfuss, T., & Galli, E. (2021). Update on treatment in multiple sclerosis. Presse Medicale, 50(2), 104068. https://doi.org/10.1016/j.lpm.2021.104068

Carey, C. F., & Dall, L. (1990). Diagnosis of cellulitis in the immunocompromised host. The Canadian Journal of Infectious Diseases, 1(4), 133–135. https://doi.org/10.1155/1990/649417

Cavalla, F., Letra, A., Silva, R. M., & Garlet, G. P. (2021). Determinants of Periodontal/Periapical Lesion Stability and Progression. Journal of Dental Research, 100(1), 29–36. https://doi.org/10.1177/0022034520952341

Cotti, E., Mezzena, S., Schirru, E., Ottonello, O., Mura, M., Ideo, F., Susnik, M., & Usai, P. (2018). Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti-tumor Necrosis Factor Alpha Therapy. Journal of Endodontics, 44(12), 1777–1782. https://doi.org/10.1016/j.joen.2018.09.004

Cox, K. D., Makara, M., Maldonado, J. O., Frantsve-Hawley, J., Carsons, S. E., & Sankar, V. (2026). Exploring the Interplay of Oral and Systemic Pathology in Sjögren's Disease. Journal of Dental Research, 105(1), 8–15. https://doi.org/10.1177/00220345251379445

Dai, X., Fan, Y., & Zhao, X. (2025). Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduction and Targeted Therapy, 10(1), 102. https://doi.org/10.1038/s41392-025-02168-0

De Rossi, S. S., & Glick, M. (1998). Lupus erythematosus: considerations for dentistry. Journal of the American Dental Association, 129(3), 330–339. https://doi.org/10.14219/jada.archive.1998.0207

Di Matteo, A., Bathon, J. M., & Emery, P. (2023). Rheumatoid arthritis. Lancet, 402(10416), 2019–2033. https://doi.org/10.1016/S0140-6736(23)01525-8

do Nascimento, I. V., Rodrigues, M. I. Q., Isaias, P. H. C., Barros-Silva, P. G., Sousa, F. B., Nunes Alves, A. P. N., & Mota, M. R. L. (2022). Chronic systemic corticosteroid therapy influences the development of pulp necrosis and experimental apical periodontitis, exacerbating the inflammatory process and bone resorption in rats. International Endodontic Journal, 55(6), 646–659. https://doi.org/10.1111/iej.13724

do Nascimento, T. A. M., Verner, F. S., Lemos, C. A. A., & Junqueira, R. B. (2025). Association between Apical Periodontitis and Autoimmune Diseases: A Systematic Review with Meta-analysis. Journal of Endodontics, 51(5), 562–570. https://doi.org/10.1016/j.joen.2025.01.021

Donaldson, M., Epstein, J., & Villines, D. (2014). Managing the care of patients with Sjögren syndrome and dry mouth: comorbidities, medication use and dental care considerations. Journal of the American Dental Association, 145(12), 1240–1247. https://doi.org/10.14219/jada.2014.83

Dropulic, L. K., & Lederman, H. M. (2016). Overview of Infections in the Immunocompromised Host. Microbiology Spectrum, 4(4), 10.1128/microbiolspec.DMIH2-0026-2016. https://doi.org/10.1128/microbiolspec.DMIH2-0026-2016

Duduveche, A. E., Ocroteala, L., & Mirea, A. A. (2026). Beyond Oral Health: Personalized Strategies for Managing Oral Infections in Neutropenic Patients. Journal of Personalized Medicine, 16(1), 53. https://doi.org/10.3390/jpm16010053

Falk, H., Hugoson, A., & Thorstensson, H. (1989). Number of teeth, prevalence of caries and periapical lesions in insulin-dependent diabetics. Scandinavian Journal of Dental Research, 97(3), 198–206. https://doi.org/10.1111/j.1600-0722.1989.tb01603.x 

Fan, Y., Lyu, P., Bi, R., Cui, C., Xu, R., Rosen, C. J., Yuan, Q., & Zhou, C. (2023). Creating an atlas of the bone microenvironment during oral inflammatory-related bone disease using single-cell profiling. eLife, 12, e82537. https://doi.org/10.7554/eLife.82537

Flügge, T., Gross, C., Ludwig, U., Schmitz, J., Nahles, S., Heiland, M., & Nelson, K. (2023). Dental MRI-only a future vision or standard of care? A literature review on current indications and applications of MRI in dentistry. Dentomaxillofacial Radiology, 52(4), 20220333. https://doi.org/10.1259/dmfr.20220333

Fox, R. I., Fox, C. M., Gottenberg, J. E., & Dörner, T. (2021). Treatment of Sjögren's syndrome: current therapy and future directions. Rheumatology, 60(5), 2066–2074. https://doi.org/10.1093/rheumatology/kez142

García-Ríos, P., Pecci-Lloret, M. P., & Oñate-Sánchez, R. E. (2022). Oral Manifestations of Systemic Lupus Erythematosus: A Systematic Review. International Journal of Environmental Research and Public Health, 19(19), 11910. https://doi.org/10.3390/ijerph191911910

Graves, D. T., Oates, T., & Garlet, G. P. (2011). Review of osteoimmunology and the host response in endodontic and periodontal lesions. Journal of Oral Microbiology, 3, 10.3402/jom.v3i0.5304. https://doi.org/10.3402/jom.v3i0.5304

Greiser, A., Christensen, J., Fuglsig, J. M. C. S., Johannsen, K. M., Nixdorf, D. R., Burzan, K., Lauer, L., Krueger, G., Hayes, C., Kettless, K., Ulrici, J., & Spin-Neto, R. (2024). Dental-dedicated MRI, a novel approach for dentomaxillofacial diagnostic imaging: technical specifications and feasibility. Dentomaxillofacial Radiology, 53(1), 74–85. https://doi.org/10.1093/dmfr/twad004

Guerrero-Gironés, J., Ros-Valverde, A., Pecci-Lloret, M. P., Rodríguez-Lozano, F. J., & Pecci-Lloret, M. R. (2021). Association between Pulpal-Periapical Pathology and Autoimmune Diseases: A Systematic Review. Journal of Clinical Medicine, 10(21), 4886. https://doi.org/10.3390/jcm10214886

Hahn, C. L., & Liewehr, F. R. (2007). Update on the adaptive immune responses of the dental pulp. Journal of Endodontics, 33(7), 773–781. https://doi.org/10.1016/j.joen.2007.01.002

Hammad, R. N., Ahmad, S. A., & Rasool, M. I. (2024). Impact of Biologic and Disease-Modifying Anti-rheumatic Drug (DMARD) Therapies on Oral Health in Rheumatologic Patients: A Case-Control Study. Cureus, 16(11), e73179. https://doi.org/10.7759/cureus.73179

Hammad, Y., Neal, T. W., & Schlieve, T. (2022). Admission C-reactive protein, WBC count, glucose, and body temperature in severe odontogenic infections: a retrospective study using severity scores. Oral surgery, Oral medicine, Oral Pathology and Oral Radiology, 133(6), 639–642. https://doi.org/10.1016/j.oooo.2021.11.002

Handley, G., & Hand, J. (2022). Adverse Effects of Immunosuppression: Infections. Handbook of Experimental Pharmacology, 272, 287–314. https://doi.org/10.1007/164_2021_550

Hargreaves, K. M., & Costello, A. (1990). Glucocorticoids suppress levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes. Clinical Pharmacology and Therapeutics, 48(2), 168–178. https://doi.org/10.1038/clpt.1990.132

Heikkinen, J., Jokihaka, V., Nurminen, J., et al. (2023). MRI of odontogenic maxillofacial infections: diagnostic accuracy and reliability. Oral Radiology, 39(2), 364–371. https://doi.org/10.1007/s11282-022-00646-7

Hu, Y., Gao, Y., Chen, Y., Xu, B., Sun, X., Zhang, W., & Wu, I. X. (2025). Dental and oral symptoms and the risk of incident systemic lupus erythematosus: a prospective study of 438,555 UK biobank participants. BMC Oral Health, 25(1), 1475. https://doi.org/10.1186/s12903-025-06788-4

Hussain, Y., & Khan, H. (2022). Immunosuppressive Drugs. Encyclopedia of Infection and Immunity, 726–740. https://doi.org/10.1016/B978-0-12-818731-9.00068-9

Ideo, F., Niazi, S., Chessa, L., Miglianti, M., Bardini, G., Mannocci, F., & Cotti, E. (2024). Prevalence of Apical Periodontitis in Patients with Autoimmune Liver Diseases on Immune Suppressants and Immune Modulators: A Cross-sectional Study. Journal of Endodontics, 50(6), 784–791. https://doi.org/10.1016/j.joen.2024.02.026

Isaacs, J. D., & Burmester, G. R. (2020). Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs. Annals of the Rheumatic Diseases, 79(8), 991–993. https://doi.org/10.1136/annrheumdis-2020-218019

Isett, J., Reader, A., Gallatin, E., Beck, M., & Padgett, D. (2003). Effect of an intraosseous injection of depo-medrol on pulpal concentrations of PGE2 and IL-8 in untreated irreversible pulpitis. Journal of Endodontics, 29(4), 268–271. https://doi.org/10.1097/00004770-200304000-00010

Jacobsen, L. M., & Schatz, D. A. (2026). Type 1 Diabetes: A Review. JAMA, 335(12), 1070–1083. https://doi.org/10.1001/jama.2026.0048

Karataş, E., Kul, A., Camilleri, J., & Yonel, Z. (2023). Association between rheumatoid arthritis and pulpal-periapical pathology: a systematic review. Clinical Oral Investigations, 27(12), 7019–7028. https://doi.org/10.1007/s00784-023-05305-7

Karataş, E., Kul, A., & Tepecik, E. (2020). Association between Rheumatoid Arthritis and Apical Periodontitis: A Cross-sectional Study. European Endodontic Journal, 5(2), 155–158. https://doi.org/10.14744/eej.2019.52824

Khalighinejad, N., Aminoshariae, M. R., Aminoshariae, A., Kulild, J. C., Mickel, A., & Fouad, A. F. (2016). Association between Systemic Diseases and Apical Periodontitis. Journal of Endodontics, 42(10), 1427–1434. https://doi.org/10.1016/j.joen.2016.07.007

Khavandgar, Z., Warner, B. M., & Baer, A. N. (2024). Evaluation and management of dry mouth and its complications in rheumatology practice. Expert Review of Clinical Immunology, 20(1), 1–19. https://doi.org/10.1080/1744666X.2023.2268283

Kim, S., & Dörscher-Kim, J. (1989). Hemodynamic regulation of the dental pulp in a low compliance environment. Journal of Endodontics, 15(9), 404–408. https://doi.org/10.1016/S0099-2399(89)80172-4

Labrosse, R., & Haddad, E. (2023). Immunodeficiency secondary to biologics. The Journal of Allergy and Clinical Immunology, 151(3), 686–690. https://doi.org/10.1016/j.jaci.2023.01.012

Lee, C. Y., & Chan, K. H. (2024). Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis. Pharmaceutics, 16(1), 120. https://doi.org/10.3390/pharmaceutics16010120

Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023). Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduction and Targeted Therapy, 8(1), 152. https://doi.org/10.1038/s41392-023-01400-z

Lim, W., Park, C., Shim, M. K., Lee, Y. H., Lee, Y. M., & Lee, Y. (2014). Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper. British Journal of Pharmacology, 171(3), 735–745. https://doi.org/10.1111/bph.12491

Limeira, F. I. R., Arantes, D. C., de Souza Oliveira, C., de Melo, D. P., Magalhães, C. S., & Bento, P. M. (2020). Root Canal Treatment and Apical Periodontitis in a Brazilian Population with Type 1 Diabetes Mellitus: A Cross-sectional Paired Study. Journal of Endodontics, 46(6), 756–762. https://doi.org/10.1016/j.joen.2020.02.010

Liu, S. C., Lu, M. C., & Koo, M. (2025). Oral Manifestations of Sjögren's Syndrome: Recognition, Management, and Interdisciplinary Care. Medicina, 62(1), 5. https://doi.org/10.3390/medicina62010005

Long, A., Kleiner, A., & Looney, R. J. (2023). Immune dysregulation. The Journal of Allergy and Clinical Immunology, 151(1), 70–80. https://doi.org/10.1016/j.jaci.2022.11.001

Mahmoud, S. H., Grawish, M.el-A., Zaher, A. R., El-Embaby, A., Karrouf, G. I., & Sobh, M. A. (2010). Influence of selective immunosuppressive drugs on the healing of exposed dogs' dental pulp capped with mineral trioxide aggregate. Journal of Endodontics, 36(1), 95–99. https://doi.org/10.1016/j.joen.2009.10.019

Mannocci, F., Koller, G., & Ravindran, S. (2025). The prevalence and healing of apical periodontitis in patients with autoimmune diseases. International Endodontic Journal, 58(6), 804–808. https://doi.org/10.1111/iej.14214

Márton, I. J., & Kiss, C. (2000). Protective and destructive immune reactions in apical periodontitis. Oral Microbiology and Immunology, 15(3), 139–150. https://doi.org/10.1034/j.1399-302x.2000.150301.x

Mathews, S. A., Kurien, B. T., & Scofield, R. H. (2008). Oral manifestations of Sjögren's syndrome. Journal of Dental Research, 87(4), 308–318. https://doi.org/10.1177/154405910808700411

Meng, Q., Ma, J., Cui, J., Gu, Y., & Shan, Y. (2024). Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment. Frontiers in Immunology, 15, 1468469. https://doi.org/10.3389/fimmu.2024.1468469

Mota, M. E., Siqueira, J. F., Jr, Rôças, I. N., Abreu Alves, F., Chagas Jaguar, G., Bertoldi Franco, J., Schmidt Filho, J., & Moreira, M. S. (2025). Endodontic Treatment in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study. Journal of Endodontics, 51(1), 35–42. https://doi.org/10.1016/j.joen.2024.10.014

Mustafa S. S. (2023). Steroid-induced secondary immune deficiency. Annals of Allergy, Asthma & Immunology, 130(6), 713–717. https://doi.org/10.1016/j.anai.2023.01.010

Muszyński, D., Kucharski, R., Marek-Trzonkowska, N., Kalinowska, M., Brzóska, A., Bolcewicz, M., Kalinowski, L., & Kaźmierczak-Siedlecka, K. (2025). Treatment of xerostomia in Sjögren's syndrome - what effect does it have on the oral microbiome?. Frontiers in Cellular and Infection Microbiology, 15, 1484951. https://doi.org/10.3389/fcimb.2025.1484951

Nair P. N. (2004). Pathogenesis of apical periodontitis and the causes of endodontic failures. Critical Reviews in Oral Biology and Medicine, 15(6), 348–381. https://doi.org/10.1177/154411130401500604

Neal, T. W., & Schlieve, T. (2022). Complications of Severe Odontogenic Infections: A Review. Biology, 11(12), 1784. https://doi.org/10.3390/biology11121784

Niazi, S. A., & Bakhsh, A. (2022). Association between Endodontic Infection, Its Treatment and Systemic Health: A Narrative Review. Medicina, 58(7), 931. https://doi.org/10.3390/medicina58070931

Nishi, H., Ohta, K., Kuramoto, Y., et al. (2022). Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy. Scientific Reports, 12(1), 2483. https://doi.org/10.1038/s41598-022-06485-0

Parentelli, A. S., Lopes, A. A., Rieux-Laucat, F., & Hermine, O. (2025). Systemic auto-inflammatory diseases, auto-immune diseases and immune deficiencies: From independent to overlapped diseases approach. Autoimmunity Reviews, 24(11), 103901. https://doi.org/10.1016/j.autrev.2025.103901

Parisi, E., & Glick, M. (2003). Immune suppression and considerations for dental care. Dental Clinics of North America, 47(4), 709–vii. https://doi.org/10.1016/s0011-8532(03)00038-7

Patel, J., Prasad, R., Bryant, C., Connolly, H., Teasdale, B., & Moosajee, S. (2021). Multiple sclerosis and its impact on dental care. British Dental Journal, 231(5), 281–286. https://doi.org/10.1038/s41415-021-3333-0

Petruzzi, M., Della Vella, F., Squicciarini, N., Lilli, D., Campus, G., Piazzolla, G., Lucchese, A., & van der Waal, I. (2023). Diagnostic delay in autoimmune oral diseases. Oral Diseases, 29(7), 2614–2623. https://doi.org/10.1111/odi.14480

Piras, V., Usai, P., Mezzena, S., Susnik, M., Ideo, F., Schirru, E., & Cotti, E. (2017). Prevalence of Apical Periodontitis in Patients with Inflammatory Bowel Diseases: A Retrospective Clinical Study. Journal of Endodontics, 43(3), 389–394. https://doi.org/10.1016/j.joen.2016.11.004

Pisetsky D. S. (2023). Pathogenesis of autoimmune disease. Nature reviews. Nephrology, 19(8), 509–524. https://doi.org/10.1038/s41581-023-00720-1

Pohl, S., Akamp, T., Smeda, M., Uderhardt, S., Besold, D., Krastl, G., Galler, K. M., Buchalla, W., & Widbiller, M. (2024). Understanding dental pulp inflammation: from signaling to structure. Frontiers in Immunology, 15, 1474466. https://doi.org/10.3389/fimmu.2024.1474466

Poyato-Borrego, M., Segura-Sampedro, J. J., Martín-González, J., Torres-Domínguez, Y., Velasco-Ortega, E., & Segura-Egea, J. J. (2020). High Prevalence of Apical Periodontitis in Patients With Inflammatory Bowel Disease: An Age- and Gender- matched Case-control Study. Inflammatory Bowel Diseases, 26(2), 273–279. https://doi.org/10.1093/ibd/izz128

Pucinelli, C. M., Nelson-Filho, P., Lucisano, M. P., León, J. E., Faccioli, L. H., Sorgi, C. A., Silva, C. M. P. C., Silva, L. A. B. D., & Silva, R. A. B. D. (2025). M1 and M2 macrophages markers are alternately expressed during periapical lesion development. Journal of Applied Oral Science, 33, e20240579. https://doi.org/10.1590/1678-7757-2024-0579

Raber-Durlacher, J. E., Laheij, A. M., Epstein, J. B., Epstein, M., Geerligs, G. M., Wolffe, G. N., Blijlevens, N. M., & Donnelly, J. P. (2013). Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Supportive Care in Cancer, 21(6), 1621–1627. https://doi.org/10.1007/s00520-012-1706-2

Ramos-Casals, M., Baer, A. N., Brito-Zerón, M. D. P., et al. (2025). 2023 International Rome consensus for the nomenclature of Sjögren disease. Nature Reviews. Rheumatology, 21(7), 426–437. https://doi.org/10.1038/s41584-025-01268-z

Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., et al. (2020). EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Annals of the Rheumatic Diseases, 79(1), 3–18. https://doi.org/10.1136/annrheumdis-2019-216114

Rautaporras, N., Uittamo, J., Furuholm, J., Marinescu Gava, M., & Snäll, J. (2023). Deep odontogenic infections - Computed tomography imaging-based spreading routes and risk for airway obstruction. Journal of Stomatology, Oral and Maxillofacial Surgery, 124(4), 101424. https://doi.org/10.1016/j.jormas.2023.101424

Rihab, B., Lina, E. H., Noémie, S. T., Jean, S., & Marjolaine, G. (2023). The experience of dry mouth and screening for Sjogren's syndrome by the dentist: patient-reported experiences. BMC Oral Health, 23(1), 1010. https://doi.org/10.1186/s12903-023-03727-z

Roberts, M. B., & Fishman, J. A. (2021). Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression". Clinical Infectious Diseases, 73(7), e1302–e1317. https://doi.org/10.1093/cid/ciaa1189

Sabat, R., Alavi, A., Wolk, K., Wortsman, X., McGrath, B., Garg, A., & Szepietowski, J. C. (2025). Hidradenitis suppurativa. Lancet, 405(10476), 420–438. https://doi.org/10.1016/S0140-6736(24)02475-9

Saccucci, M., Di Carlo, G., Bossù, M., Giovarruscio, F., Salucci, A., & Polimeni, A. (2018). Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management. Journal of Immunology Research, 2018, 6061825. https://doi.org/10.1155/2018/6061825

Segura-Egea, J. J., Martín-González, J., & Castellanos-Cosano, L. (2015). Endodontic medicine: connections between apical periodontitis and systemic diseases. International Endodontic Journal, 48(10), 933–951. https://doi.org/10.1111/iej.12507

Saleem, S., Anwar, A., Fayyaz, M., Anwer, F., & Anwar, F. (2019). An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis. Cureus, 11(7), e5246. https://doi.org/10.7759/cureus.5246

Song, X., Liang, H., Nan, F., Chen, W., Li, J., He, L., Cun, Y., Li, Z., Zhang, W., & Zhang, D. (2025). Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets. MedComm, 6(7), e70262. https://doi.org/10.1002/mco2.70262

Song, Y., Li, J., & Wu, Y. (2024). Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduction and Targeted Therapy, 9(1), 263. https://doi.org/10.1038/s41392-024-01952-8

Tavakoli, P., Vollmer-Conna, U., Hadzi-Pavlovic, D., & Grimm, M. C. (2021). A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Reviews, 42, 1603990. https://doi.org/10.3389/phrs.2021.1603990

Vaddi, A., Parasher, P., & Khurana, S. (2025). Beyond X-Rays: Unveiling the Future of Dental Diagnosis with Dental Magnetic Resonance Imaging. Diagnostics (Basel, Switzerland), 15(9), 1153. https://doi.org/10.3390/diagnostics15091153

Wang, L., Wang, F. S., & Gershwin, M. E. (2015). Human autoimmune diseases: a comprehensive update. Journal of Internal Medicine, 278(4), 369–395. https://doi.org/10.1111/joim.12395

Waterman, P. A., Jr, Torabinejad, M., McMillan, P. J., & Kettering, J. D. (1998). Development of periradicular lesions in immunosuppressed rats. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 85(6), 720–725. https://doi.org/10.1016/s1079-2104(98)90041-5

Wen, Y. H., Lin, Y. X., Zhou, L., Lin, C., & Zhang, L. (2024). The immune landscape in apical periodontitis: From mechanism to therapy. International Endodontic Journal, 57(11), 1526–1545. https://doi.org/10.1111/iej.14125

Wise, L. M., & Stohl, W. (2020). Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents. Frontiers in Medicine, 7, 303. https://doi.org/10.3389/fmed.2020.00303

Xu, X., Zheng, X., Lin, F., et al. (2024). Expert consensus on endodontic therapy for patients with systemic conditions. International Journal of Oral Science, 16(1), 45. https://doi.org/10.1038/s41368-024-00312-0

Yamazaki, S., Hayashi, R., Mutoh, N., Ohshima, H., & Tani-Ishii, N. (2023). Effects of Rheumatoid Arthritis on the Progression of Pulpitis and Apical Periodontitis in SKG Mice. Journal of Endodontics, 49(11), 1501–1507. https://doi.org/10.1016/j.joen.2023.08.003

Ye, L., Cao, L., Song, W., Yang, C., Tang, Q., & Yuan, Z. (2023). Interaction between apical periodontitis and systemic disease (Review). International Journal of Molecular Medicine, 52(1), 60. https://doi.org/10.3892/ijmm.2023.5263

Yu, C.Y. & Abbott, P.V. (2018), Pulp microenvironment and mechanisms of pain arising from the dental pulp: From an endodontic perspective. Australian Endodontic Journal, 44: 82-98. https://doi.org/10.1111/aej.12257

Zadik, Y., Vainstein, V., Heling, I., Neuman, T., Drucker, S., & Elad, S. (2010). Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain. Journal of Endodontics, 36(9), 1588–1592. https://doi.org/10.1016/j.joen.2010.05.004

Zecha, J. A. E. M., Raber-Durlacher, J. E., Laheij, A. M. G. A., Westermann, A. M., Epstein, J. B., de Lange, J., & Smeele, L. E. (2019). The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy. Supportive Care in Cancer, 27(10), 3667–3679. https://doi.org/10.1007/s00520-019-04925-8

Zecha, J. A. E. M., Raber-Durlacher, J. E., Laheij, A. M. G. A., Westermann, A. M., de Lange, J., & Smeele, L. E. (2022). The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated with Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma. Frontiers in Oral Health, 3, 940044. https://doi.org/10.3389/froh.2022.940044